Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "George Hill"


5 mentions found


Of those companies, 73.6% have beaten earnings expectations, FactSet data shows. Investment banks doing well, BofA not so much The major banks that posted results this week — Goldman Sachs , Morgan Stanley and Bank of America — beat earnings expectations. Bank of America shares fell more than 3% despite the company beating on both top and bottom lines. Mixed earnings picture Although nearly three-quarters of the reported earnings so far have topped expectations, the broader earnings picture is more muddled. The blended earnings growth rate, which considers the reports already out and the estimates from those still pending, sits at just 0.16%.
Persons: — Goldman Sachs, Morgan Stanley, Alastair Borthwick, Wells, Mike Mayo, Goliath, Mayo, Goldman Sachs, Wells Fargo's Mayo, Goldman, Ebrahim Poonawala, cyberattack, George Hill, Doug Anmuth, Jessica Reif Ehrlich, Canaccord Genuity, Chris Harvey Organizations: Investment, Bank of America —, Bank of America, Bank of America's, JPMorgan, Wells, of America, Deutsche, Netflix, NFLX's, Revenue, Microsoft, Exxon Mobil
Walgreens ' management just flashed a warning sign for the year ahead, and Deutsche Bank thinks investors need to stay on the sidelines on the stock. The bank downgraded the pharmacy stock to hold from buy on Wednesday and lowered its price target to $34 per share price from $46. WBA YTD mountain Walgreens stock is down more than 23% so far this year. Hill noted that Walgreens now expects fiscal 2023 adjusted EBITDA between losses of $380 million and $340 million. Walgreens also cut its fiscal fourth-quarter earnings guidance and reported a weaker-than-expected fiscal third-quarter profit .
Persons: George Hill, Hill, — CNBC's Michael Bloom Organizations: Walgreens, Deutsche Bank, WBA Locations: F3Q
U.S. health insurance firm Humana is the only major stock from around the world to have risen by more than 10% every year for the past decade. Here's what some are saying: Deutsche Bank Equity analyst George Hill bumped up the bank's price target to $568 (10% upside) on April 26. RBC Capital Markets Ben Hendrix retired the bank's outperform rating and price target of $637 on April 27. The investment bank maintains an "in-line" or hold rating on the stock with a price target of $637. Jefferies' analysts raised their price target to $614 with a buy-rating on April 27.
Persons: , Humana's, George Hill, JP Morgan Lisa Gill, HUM, UBS Kevin Caliendo, Ben Hendrix, Morgan Stanley's, Jefferies Organizations: Humana, CNBC Pro, Affordable, NYSE, Deutsche Bank Equity, MLR, UBS, Swiss, Medicare, RBC Locations: Kentucky, U.S
Walgreens could stand to benefit from recent business moves if they are executed well, Deutsche Bank says. The investor focus at the meeting was the deal to acquire Summit/Village MD as the company transitions to health care services. Hill said the deal makes Walgreens one of the largest investor-owned, multi-payer primary care businesses, though UnitedHealth will still remain the biggest. Hill said Summit has a specialty business that could help Walgreen's expand its total addressable market. Given Walgreens has majority ownership, Hill said it could take Summit public in 2023 through an initial public offering.
These so-called Star Ratings are designed to help consumers evaluate the quality of Medicare Advantage (MA) and Medicare Part D prescription drug plans, according to the CMS . Humana stock was left for dead at the beginning of the year when it warned about Medicare Advantage growth. Humana is "poised to take market share" in Medicare Advantage this enrollment season. Furthermore, we believe Humana offers a superior Medicare Advantage package and represents new leadership in the health care industry. Earlier this month, Humana released the details of its newly expanded and enhanced Medicare Advantage plan offering.
Total: 5